MFDS — authorised 31 December 1943
- Marketing authorisation holder: RECORDATI RARE
- Status: likely_approved
MFDS authorised Desoxyn on 31 December 1943
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS authorised it on 31 December 1943.
RECORDATI RARE holds the South Korean marketing authorisation.